2008
DOI: 10.1016/j.healthpol.2008.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
39
0
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(42 citation statements)
references
References 14 publications
0
39
0
1
Order By: Relevance
“…Greater attention has been given to hospital's technical efficiency and a growing number of studies in recent decades, so that to compare the relative performance given the need to ensure the best use of scarce resources [6], especially when facing the challenges in demands for high quality medical services over the long term in an ageing society [7,8]. The efficiency concept used is that of technical efficiency.…”
Section: Introductionmentioning
confidence: 99%
“…Greater attention has been given to hospital's technical efficiency and a growing number of studies in recent decades, so that to compare the relative performance given the need to ensure the best use of scarce resources [6], especially when facing the challenges in demands for high quality medical services over the long term in an ageing society [7,8]. The efficiency concept used is that of technical efficiency.…”
Section: Introductionmentioning
confidence: 99%
“…As a result, orphan drugs are likely to seize an increasingly greater proportion of the annually approved pharmaceutical products and occupy larger fractions of healthcare budgets. In effect, sales of biopharmaceutical drugs, which include many orphan drugs, have increased by over 100% in the US and over 200% in most European nations during 2001-2005 [7].…”
Section: Introductionmentioning
confidence: 99%
“…Definición que se complementa con los aportes de Essén y Lindblad (2013) y Rosemberg-Yunger et al, (2008), quienes agregan que la innovación además representa beneficio y avance para los individuos y organizaciones, en términos de creación de un nuevo producto o servicio, disminución de costos y mejora de productos, procesos o modelos de negocio existentes. A pesar de este aporte, aún es difícil conceptualizar la innovación y esta dificultad se extiende a las investigaciones en salud, dónde identificar una definición en la que coincidan los autores es un proceso complejo, caracterizado por aportes teóricos que divergen entre sí y que en su mayoría se orientan a visualizar la innovación cómo una serie de procedimientos que deben documentarse y comunicarse para hacerlos extensivos en las diferentes organizaciones del sector salud (Weberg, 2009;Helfrich et al, 2007;Estrabrooks et al, 2006).…”
Section: Innovación En El Sector Saludunclassified